The causal relationship between HIV and AIDS was established in the mid-1980s. In 2008, French researchers won a Nobel Prize ...
With the help of new scientific and technological developments, the HIV/Aids research community is increasingly turning to an ...
Scientists have developed Lenacapavir, a twice-yearly injection that cuts HIV infection risk by 96% in groundbreaking trials.
A first-of-its-kind treatment center aimed at helping those living with or at risk of HIV is now open in Minneapolis.
A man who has lived with HIV for 12 years is part of a campaign to raise awareness of the stigma associated with the ...
A new HIV prevention drug, lenacapavir, has shown 100% effectiveness in women and near-perfect results in men during trials.
In two mid-Michigan school districts where the HIV education curriculum was discovered to be out of date a year ago by 6 News ...
Lenacapavir, a new twice-yearly injection, offers 96% HIV prevention efficacy, surpassing daily oral PrEP. For oral ...
Ending AIDS as a public health threat by 2030 is a real possibility, tantalizingly close. But the job is not yet done.
Even though it has been decades since HIV / AIDS entered the public domain, certain myths and misconceptions continue to endure, a ministry leader contends. “Some are shunned by their families, by ...
Argentines living with HIV/AIDS and medics say spending cuts under libertarian President Javier Milei are hurting treatment ...
The National AIDS Memorial has honored Dan Bernal, UCSF vice chancellor for community and government relations, for his ...